Systemic JIA — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Switch to IL-6 receptor inhibition with tocilizumab
Explanation lettering: E = shown as A · D = shown as C · A = shown as D · C = shown as E
C is correct. IL-1 and IL-6 inhibition are the core cytokine strategies in Still disease; persistent articular activity after an adequate IL-1 trial makes tocilizumab a coherent switch. A combines biologics without a supported safety strategy. B and E bypass better-supported Still targets. D normalises prolonged glucocorticoid exposure instead of pursuing clinically inactive disease off steroids.
Reference: EULAR/PReS recommendations for diagnosis and management of Still disease: https://pmc.ncbi.nlm.nih.gov/articles/PMC11672000/